Anaplastic Astrocytoma - 215 Studies Found
Terminated |
: High-Dose Vorinostat and Fractionated Stereotactic Body Radiation Therapy in Treating Patients With Recurrent Glioma :
|
Completed |
: A Pilot Feasibility Study of Oral 5-Fluorocytosine and Genetically-Modified Neural Stem Cells Expressing E.Coli Cytosine Deaminase for Treatment of Recurrent High Grade Gliomas :
: |
Terminated |
: Aminolevulinic Acid During Surgery in Treating Patients With Malignant Brain Tumors :
|
Completed |
: Aflibercept, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma Multiforme, Gliosarcoma, or Other Malignant Glioma :
|
Active, not recruiting |
: Vorinostat and Temozolomide in Treating Patients With Malignant Gliomas :
|
Terminated |
: Erlotinib in Treating Patients With Recurrent Malignant Glioma or Recurrent or Progressive Meningioma :
|
Completed |
: A Phase 1, Open-Label, Dose Escalation Study of ANG1005 in Patients With Malignant Glioma : Recurrent or Progressive Malignant Glioma : 2007-10-02 : Drug: ANG1005 IV infusion once every 21 days |
Completed |
: Dose Response of Functionally Critical Brain Regions for Brain Radiotherapy : Brain Tumors : 2010-06-22 : Procedure: fMRI Evaluation Functional magnetic resonance imaging (fMRI) uses MR imaging to measure the t |
Active, not recruiting |
: Veliparib, Radiation Therapy, and Temozolomide in Treating Younger Patients With Newly Diagnosed Diffuse Pontine Gliomas :
|
Recruiting |
: Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma : Brain and Central Nervous System Tumors : 2009-04-22 :
|